Highlight
– Prolonged hospitalization (PLOS) post-hematopoietic cell transplantation (HCT) is associated with worse pre-transplant quality of life (QOL), symptom burden, and depression.
– Patients experiencing PLOS exhibit sustained worse QOL, elevated symptom burden, and depressive symptoms up to six months after transplantation.
– PLOS is linked to increased risk of mortality and rehospitalization within the first year post-HCT.
– Identifying patients at risk for PLOS allows prioritization of augmented supportive and palliative care interventions.
